In this study, quantitative assessments of ILA using AI will be combined with visual assessments that semi-quantify the visual extent of ILA in 5% increments, as well as the pattern of HRCT findings in line with the 2022 IPF international guidelines [7]. The gene discussed is TNFRSF9; the disease is idiopathic pulmonary fibrosis.